Point-of-Care Glucose Testing Market

Global Point-of-Care Glucose Testing Market by Type (Freestyle Lite, Accu-Chek Inform II, StatStrip, Onetouch Verio Flex, Accu Check Aviva Meter, True Metrix, Bayer CONTOUR Blood Glucose Monitoring System, i-STAT and Other Product Type), by Testing Site (Fingertip Testing and Alternate Site Testing), by end users (Professional Diagnostic Centres, Hospitals & Clinics, home care settings, and Research labs) and Region - 2022 to 2032

Newly-released Point-of-Care Glucose Testing Market analysis report by Transparency Market Research reveals that global sales of Point-of-Care Glucose Testing in 2021 were held at US$ 3.7 Bn. With a CAGR of 4.3% during 2022 - 2032, the market is projected to reach a valuation of US$ 5.8 Bn by 2032.

Accu-Chek Inform II product type is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 5.1% during 2022 – 2032. The market is projected to witness an absolute dollar growth of US$ 2 Bn.

Revenue of Point-of-Care Glucose Testing Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Point-of-Care Glucose Testing Market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Market increased at around 3.5% CAGR.

The key drivers that will impact the market include the surge in the geriatric population, the instant and timely results that point-of-care (POC) screening can provide, and the increased usage of Electronic Medical Records (EMRs).

Skilled personnel are not adequate enough which necessitates the adoption of glucose POC diagnostics. Diabetes increasing the risk of COVID-19-related mortality is another key factor boosting market growth.

According to Transparency Market Research, Market revenue would increase 1.5X between 2022 and 2032, reaching roughly US$ 5.8 Bn by 2032.

Which Factors are Propelling Point-of-Care Glucose Testing Market Demand?

The increasing number of diabetes patients as well as technological advancements and increased awareness about the usage of point-of-care glucose testing are contributing to the market's growth. As there is a rise in needle-free blood glucose monitoring devices, several key players are offering painless diabetes care to patients.

Clinical & Laboratories Standard Institute, an International Organization recently regulated the guideline for accuracy in point-of-care glucose testing for standardization. In the critical care unit, the POCT gadget is widely employed. In recent years, there has been a rise in the need for POC testing.

Diabetes control has been the highest priority of healthcare professionals which can help to reduce the death rate. Diabetes Research Foundation mentions that diabetes will decrease the life expectancy in COVID-19 patients by 50%.

Growing diabetes awareness, limited healthcare facilities, and less number of healthcare professionals in Asian nations will drive the point-of-care glucose testing systems market. As a result, there is an opportunity to save money on healthcare while also improving the quality of care.

What are the restraints of the Point-of-Care Glucose Testing Market?

One of the key factors that are restricting the market's growth is a lack of understanding of the test. The test accuracy is another stumbling block to market expansion.

There are a lot of false detection tests that are discovered. Despite the fact that these tests were developed after substantial research and development, they are nevertheless susceptible to misdiagnosis.

Regional Insights

Which Region is projected to Offer the Largest Opportunity for Point-of-Care Glucose Testing Market?

North America held the largest market in 2021, contributing for even more than 40% of overall global sales. Several major market participants, including Abbott, Nova Biomedical, and Prodigy Diabetes Care, LLC, are based in this region. As a result, the diabetes testing products are easily accessible and available so they expanded in less timeframe, contributing to boosting the regional market's revenue.

Furthermore, the government has increased spending on healthcare, especially on diabetes, which is one of the factors driving the regional market growth.

POC tests are in high demand due to their benefits, including quick, simple, portable diagnosis and self-monitoring. These devices serve patients in hospitals, medical screenings, clinics, and homes, as well as making diagnosis and monitoring easier.

Constantly expanding healthcare infrastructure and an elevated risk of diabetes are projected to drive the market in the Asia Pacific. An increase in the deployment of smaller variants, as well as the hesitation or avoidance of hospital and clinic appointments, is boosting the demand.

POC glucose diagnostics is projected to grow more commonly in ORs, emergency rooms, Critical Care Units, diagnostic labs, and hospitals because of their speedy and accurate results.

Country-wise Insights

U.S. Analysis

The market in the U.S. is projected to reach a valuation of US$ 2.1 Bn by 2032. Growing at a CAGR of 4.5% during 2022 – 2032, the market in the country is expected to gross an absolute dollar opportunity of US$ 732 Mn.

U.K. Analysis

The market in the country is expected to reach US$ 222 Mn by 2032. During the forecast period, the market in the country is expected to garner an absolute dollar opportunity of around US$ 70 Mn during 2022 - 2032.

Category-wise Insights

Which Product type of Market is expected to Score the Highest Growth in the Coming Years?

Accu-Check Inform II accounted for more than 54% of worldwide revenue in 2021 and further it is expected to grow consistently over the forecast period. A POC monitor device allows the patients to self-monitor their blood glucose level at home which helps them to perform normal activities easily.

Also, these devices are now used in inpatient settings since they are simple to use and provide fast results.

On the other hand over the projected period, the FreeStyle Lite product category is expected to increase at the fastest rate. Abbott offers the FreeStyle Lite, which comes in a small package with a built-in portlight and backlight, making it convenient for patients who have a busy schedule.

Blood sugar levels are measured using samples taken from the hand, upper limbs, fingers, forearm, and thigh. The FreeStyle Lite meter should only be used with the FreeStyle control solution and testing strips, as using other monitoring tools and test strips may result in wrong results.

Which End User of the Market is expected to Score the Highest Growth in the Coming Years?

Professional diagnostic centers, hospitals & clinics, home care settings, and Research labs are among the key end-users in the global market. The home care settings segment dominated the global market.

During the forecast period, the market through this segment is expected to increase at the fastest rate. The rise in acceptance of home health care, technological developments and cost-effectiveness to other traditional treatments is contributing to an increase in demand for home care settings.

Competitive Analysis

Some of the major key players featured in the report are F. Hoffmann-La Roche, Nova Biomedical, Nipro, Platinum Equity Advisors, ACON Laboratories, Trividia Health, Prodigy Diabetes Care, Bayer AG/Ascensia Diabetes Care Holdings AG, Abbott and EKF Diagnostics.

Some of the recent developments of Market key providers are as follows:

  • In September 2021, FDA cleared the StatStrip Glucose Hospital Meter glucose meter. It is used with critically ill patients. CLIA (Clinical Laboratory Improvement Amendments) stated it can be used with ALL patients and ALL sample types, which is on display at American Association for Clinical Chemistry 2021. In the United States, the FDA considers the use of any other glucose meter with critically ill patients to be off-label and high-complexity testing under CLIA.
  • In October 2020, Abbott collaborated with Insulet Corporation to link the FreeStyle Libre innovation only with Omnipod Horizon Automated Insulin Delivery System, which is next-generation breathing and will provide personalized automated insulin delivery.

Market Segments Covered in Point-of-Care Glucose Testing Market Analysis

By Product Type

  • Freestyle Lite
  • Accu-Chek Inform II
  • StatStrip
  • Onetouch Verio Flex
  • Accu Check Aviva Meter
  • True Metrix
  • Bayer CONTOUR Blood Glucose Monitoring System
  • i-STAT
  • Other Product Type

By End User

  • Professional Diagnostic Centres
  • Hospital and Clinics
  • Home care settings
  • Research Lab

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa(MEA)

Attribute

Details

Global Market (2022)

US$ 3.8 Bn

Global Market (2032)

US$ 5.8 Bn

Global Market CAGR (2022 – 2032)

4.3%

U.S. Market CAGR (2022 – 2032)

4.5%

Key Companies Profiled

  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Nipro
  • PlatInium Equity Advisors
  • Nova Biomedical
  • ACON Laboratories
  • Trividia Health
  • Prodigy Diabetes Care
  • Bayer AG/Ascensia Diabetes Care Holdings AG
  • EKF Diagnostics

Frequently Asked Questions

How much is the current worth of the Point-of-Care Glucose Testing Market?

The market is worth more than US$ 3.7 Bn at present.

What is the sales forecast for Market?

The market value is projected to increase at a CAGR of around 4.3% during 2022 – 2032.

What was the last 5 year’s market CAGR?

The market value increased at a CAGR of around 3.5% during 2017 – 2021.

What is a key trend shaping the growth of the market for the Point-of-Care Glucose Testing Market?

There is a rise in the frequency of diabetic patients, which is expected to shape the demand for point-of-care glucose testing globally.

At what percentage are sales of the Market going to register growth in China?

The market in China is projected to expand at a CAGR of around 4.6% during 2022 – 2032.

What do statistics for South Korea and Japan reveal?

While the market in South Korea is expected to grow at nearly 5.7%, the market in Japan is projected to register a CAGR of nearly 5.3% during 2022 - 2032.

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

4. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032

        5.3.1. Freestyle Lite

        5.3.2. Accu-Chek Inform II

        5.3.3. StatStrip

        5.3.4. Onetouch Verio Flex

        5.3.5. Accu Check Aviva Meter

        5.3.6. True Metrix

        5.3.7. Bayer CONTOUR Blood Glucose Monitoring System

        5.3.8. i-STAT

        5.3.9. Other Product Type

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

6. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        6.3.1. Professional Diagnostic Centres

        6.3.2. Hospital and Clinics

        6.3.3. Home care settings

        6.3.4. Research Lab

    6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    6.5. Absolute $ Opportunity Analysis By End User, 2022-2032

7. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. East Asia

        7.3.5. South Asia

        7.3.6. Oceania

        7.3.7. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Product Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Argentina

            9.2.1.4. Rest of Latin America

        9.2.2. By Product Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. U.K.

            10.2.1.5. Spain

            10.2.1.6. Russia

            10.2.1.7. BENELUX

            10.2.1.8. Rest of Europe

        10.2.2. By Product Type

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By End User

    10.4. Key Takeaways

11. East Asia Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

        11.2.2. By Product Type

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By End User

    11.4. Key Takeaways

12. South Asia Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Thailand

            12.2.1.3. Malaysia

            12.2.1.4. Indonesia

            12.2.1.5. Rest of South Asia

        12.2.2. By Product Type

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By End User

    12.4. Key Takeaways

13. Oceania Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Product Type

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By End User

    13.4. Key Takeaways

14. MEA Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC

            14.2.1.2. Rest of MEA

        14.2.2. By Product Type

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Point-of-Care Glucose Testing Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Product Type

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Product Type

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Product Type

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Product Type

            15.4.2.2. By End User

    15.5. Argentina

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Product Type

            15.5.2.2. By End User

    15.6. Germany

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Product Type

            15.6.2.2. By End User

    15.7. Italy

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Product Type

            15.7.2.2. By End User

    15.8. France

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Product Type

            15.8.2.2. By End User

    15.9. U.K.

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Product Type

            15.9.2.2. By End User

    15.10. Spain

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Product Type

            15.10.2.2. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Product Type

            15.11.2.2. By End User

    15.12. BENELUX

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Product Type

            15.12.2.2. By End User

    15.13. China

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Product Type

            15.13.2.2. By End User

    15.14. Japan

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Product Type

            15.14.2.2. By End User

    15.15. South Korea

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Product Type

            15.15.2.2. By End User

    15.16. India

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Product Type

            15.16.2.2. By End User

    15.17. Thailand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Product Type

            15.17.2.2. By End User

    15.18. Malaysia

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Product Type

            15.18.2.2. By End User

    15.19. Indonesia

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Product Type

            15.19.2.2. By End User

    15.20. Australia

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Product Type

            15.20.2.2. By End User

    15.21. New Zealand

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Product Type

            15.21.2.2. By End User

    15.22. GCC Countries

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2021

            15.22.2.1. By Product Type

            15.22.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product Type

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. F. Hoffmann-La Roche Ltd.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Abbott

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Nipro

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. PlatInium Equity Advisors

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Nova Biomedical

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. ACON Laboratories

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Trividia Health

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Prodigy Diabetes Care

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Bayer AG/Ascensia Diabetes Care Holdings AG

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. EKF Diagnostics

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 3: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 4: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 5: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 6: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 7: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 9: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 10: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 12: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 13: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 15: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 18: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 19: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 20: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 21: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 22: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 23: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 24: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

List of Figure

Figure 1: Global Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 2: Global Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 3: Global Point-of-Care Glucose Testing Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 5: Global Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 8: Global Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 9: Global Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 10: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 11: Global Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 12: Global Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 13: Global Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032

Figure 14: Global Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032

Figure 15: Global Point-of-Care Glucose Testing Market Attractiveness by Region, 2022-2032

Figure 16: North America Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 17: North America Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 18: North America Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 20: North America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 23: North America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 24: North America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 25: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 26: North America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 27: North America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 28: North America Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032

Figure 29: North America Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032

Figure 30: North America Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 32: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 33: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 35: Latin America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 38: Latin America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 39: Latin America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 40: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 41: Latin America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 42: Latin America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 43: Latin America Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032

Figure 44: Latin America Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032

Figure 45: Latin America Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032

Figure 46: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 47: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 48: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 50: Europe Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 53: Europe Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 54: Europe Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 55: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 56: Europe Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 57: Europe Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 58: Europe Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032

Figure 59: Europe Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032

Figure 60: Europe Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032

Figure 61: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 62: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 63: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 64: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 65: East Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: East Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 68: East Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 69: East Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 70: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 71: East Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 72: East Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 73: East Asia Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032

Figure 74: East Asia Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032

Figure 75: East Asia Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032

Figure 76: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 77: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 78: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 79: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 80: South Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: South Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 83: South Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 84: South Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 85: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 86: South Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 87: South Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 88: South Asia Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032

Figure 89: South Asia Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032

Figure 90: South Asia Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032

Figure 91: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 92: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 93: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 94: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 95: Oceania Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 96: Oceania Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 97: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 98: Oceania Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 99: Oceania Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 100: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 101: Oceania Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 102: Oceania Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 103: Oceania Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032

Figure 104: Oceania Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032

Figure 105: Oceania Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032

Figure 106: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 107: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 108: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 109: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 110: MEA Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 111: MEA Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 112: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 113: MEA Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 114: MEA Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 115: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 116: MEA Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 117: MEA Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 118: MEA Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032

Figure 119: MEA Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032

Figure 120: MEA Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032

Copyright © Transparency Market Research, Inc. All Rights reserved